Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-27T12:20:30.840Z Has data issue: false hasContentIssue false

Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993–6

Published online by Cambridge University Press:  01 February 1999

M. CONNOLLY
Affiliation:
Department of Public Health and Epidemiology, King's College School of Medicine and Dentistry, London
N. NOAH
Affiliation:
Department of Public Health and Epidemiology, King's College School of Medicine and Dentistry, London
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A surveillance system to assess the impact and changing epidemiology of invasive meningococcal disease in Europe was set up in 1987. Since about 1991, contributors from national reference laboratories, national communicable disease surveillance centres and institutes of public health in 35 European countries provided information on all reported cases of meningococcal disease in their country. We describe some trends observed over the period 1993–6. The main findings were: the overall incidence of meningococcal disease was 1·1 per 100000 population but there was some evidence of a slow increase over time and with northern European countries tending to have a higher incidence (Kendall correlation 0·5772, P<0·001), an increasing predominance of serogroup C, and a shift in the age distribution towards teenagers and away from younger children (χ2 test for trend 44·56, P<0·0001), although about half of the cases were under 5 years of age. The overall case fatality rate was 8·3% and the most common serosubtypes were B[ratio ]15[ratio ]P1.7,16 and C[ratio ]2a[ratio ]P1.2,5.

Type
Research Article
Copyright
© 1999 Cambridge University Press